$2.59 Billion is the total value of Artal Group S.A.'s 99 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 31.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| WW | WW INTL INC | $566,207,000 | +1.0% | 14,818,300 | 0.0% | 21.88% | -2.6% | |
| LXRX | LEXICON PHARMACEUTICALS INC | $249,999,000 | +37.9% | 60,240,864 | 0.0% | 9.66% | +32.8% | |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $115,170,000 | +104.6% | 1,000,000 | +42.9% | 4.45% | +97.1% |
| BGNE | Sell | BEIGENE LTDsponsored adr | $106,086,000 | +33.3% | 640,000 | -1.5% | 4.10% | +28.4% |
| MS | Buy | MORGAN STANLEYcall | $102,240,000 | +59.7% | 2,000,000 | +33.3% | 3.95% | +53.9% |
| BABA | ALIBABA GROUP HLDG LTDsponsored ads | $95,445,000 | +26.8% | 450,000 | 0.0% | 3.69% | +22.2% | |
| MRNA | MODERNA INC | $90,099,000 | +22.9% | 4,606,298 | 0.0% | 3.48% | +18.4% | |
| BNTX | New | BIONTECH SEsponsored ads | $89,041,000 | – | 2,628,130 | +100.0% | 3.44% | – |
| AVTR | Sell | AVANTOR INC | $86,213,000 | -2.3% | 4,750,000 | -20.8% | 3.33% | -5.8% |
| XLRN | Sell | ACCELERON PHARMA INC | $63,624,000 | +7.4% | 1,200,000 | -20.0% | 2.46% | +3.5% |
| ARGX | Buy | ARGENX SEsponsored adr | $56,182,000 | +146.5% | 350,000 | +75.0% | 2.17% | +137.5% |
| EPZM | Buy | EPIZYME INC | $55,350,000 | +257.7% | 2,250,000 | +50.0% | 2.14% | +244.8% |
| FATE | FATE THERAPEUTICS INC | $39,140,000 | +26.0% | 2,000,000 | 0.0% | 1.51% | +21.4% | |
| Z | Buy | ZILLOW GROUP INCcl c cap stk | $34,455,000 | +77.8% | 750,000 | +15.4% | 1.33% | +71.3% |
| SRRK | Buy | SCHOLAR ROCK HLDG CORP | $33,557,000 | +59.8% | 2,546,040 | +8.5% | 1.30% | +53.9% |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $32,044,000 | -27.3% | 400,000 | -33.3% | 1.24% | -29.9% |
| MORF | MORPHIC HLDG INC | $31,217,000 | -5.2% | 1,819,186 | 0.0% | 1.21% | -8.7% | |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $29,220,000 | +45.7% | 3,000,000 | +20.0% | 1.13% | +40.4% |
| ATRA | Buy | ATARA BIOTHERAPEUTICS INC | $28,823,000 | +36.1% | 1,750,000 | +16.7% | 1.11% | +31.2% |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $28,650,000 | +121.1% | 600,000 | +50.0% | 1.11% | +112.9% |
| RUBY | RUBIUS THERAPEUTICS INC | $26,921,000 | +21.0% | 2,833,791 | 0.0% | 1.04% | +16.6% | |
| GOSS | GOSSAMER BIO INC | $25,148,000 | -6.9% | 1,608,968 | 0.0% | 0.97% | -10.2% | |
| PYPL | New | PAYPAL HLDGS INC | $21,634,000 | – | 200,000 | +100.0% | 0.84% | – |
| XNCR | Buy | XENCOR INC | $18,915,000 | +86.9% | 550,000 | +83.3% | 0.73% | +80.0% |
| TPTX | Sell | TURNING POINT THERAPEUTICS I | $18,687,000 | +24.2% | 300,000 | -25.0% | 0.72% | +19.7% |
| ARAV | Buy | ARAVIVE INC | $18,455,000 | +515.2% | 1,350,000 | +237.5% | 0.71% | +494.2% |
| FGEN | Buy | FIBROGEN INC | $17,156,000 | +157.8% | 400,000 | +122.2% | 0.66% | +148.3% |
| STNE | Buy | STONECO LTD | $15,956,000 | +52.9% | 400,000 | +33.3% | 0.62% | +47.4% |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $15,560,000 | -8.3% | 250,000 | -50.0% | 0.60% | -11.6% |
| UBER | UBER TECHNOLOGIES INC | $14,870,000 | -2.4% | 500,000 | 0.0% | 0.57% | -6.1% | |
| AAL | AMERICAN AIRLS GROUP INCcall | $14,340,000 | +6.3% | 500,000 | 0.0% | 0.55% | +2.4% | |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $13,912,000 | -3.7% | 100,000 | -33.3% | 0.54% | -7.3% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $13,840,000 | +8.6% | 500,000 | -28.6% | 0.54% | +4.7% |
| TCDA | TRICIDA INC | $13,586,000 | +22.3% | 360,000 | 0.0% | 0.52% | +17.7% | |
| SWTX | Buy | SPRINGWORKS THERAPEUTICS INC | $13,472,000 | +101.4% | 350,000 | +13.4% | 0.52% | +94.0% |
| PRQR | PROQR THRAPEUTICS N V | $12,883,000 | +72.0% | 1,300,000 | 0.0% | 0.50% | +66.0% | |
| HARP | New | HARPOON THERAPEUTICS INC | $12,572,000 | – | 850,000 | +100.0% | 0.49% | – |
| YMAB | Y MABS THERAPEUTICS INC | $12,500,000 | +19.9% | 400,000 | 0.0% | 0.48% | +15.6% | |
| HOOK | Sell | HOOKIPA PHARMA INC | $12,291,000 | +44.4% | 1,004,987 | -11.4% | 0.48% | +39.3% |
| ALBO | ALBIREO PHARMA INC | $11,444,000 | +27.1% | 450,200 | 0.0% | 0.44% | +22.4% | |
| DRNA | Sell | DICERNA PHARMACEUTICALS INC | $11,015,000 | -23.3% | 500,000 | -50.0% | 0.43% | -26.0% |
| SAGE | SAGE THERAPEUTICS INC | $10,829,000 | -48.5% | 150,000 | 0.0% | 0.42% | -50.5% | |
| NKTR | Sell | NEKTAR THERAPEUTICScall | $10,793,000 | -1.2% | 500,000 | -16.7% | 0.42% | -4.8% |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $10,425,000 | +430.5% | 1,000,000 | +100.0% | 0.40% | +410.1% |
| RETA | New | REATA PHARMACEUTICALS INCcl a | $10,222,000 | – | 50,000 | +100.0% | 0.40% | – |
| AGEN | AGENUS INC | $10,175,000 | +57.8% | 2,500,000 | 0.0% | 0.39% | +51.7% | |
| AXDX | Buy | ACCELERATE DIAGNOSTICS INC | $10,140,000 | +9.2% | 600,000 | +20.0% | 0.39% | +5.4% |
| MRNA | MODERNA INCcall | $9,780,000 | +22.9% | 500,000 | 0.0% | 0.38% | +18.5% | |
| BLUE | BLUEBIRD BIO INC | $8,775,000 | -4.4% | 100,000 | 0.0% | 0.34% | -7.9% | |
| INCY | Sell | INCYTE CORPcall | $8,732,000 | -52.9% | 100,000 | -60.0% | 0.34% | -54.7% |
| REPL | REPLIMUNE GROUP INC | $8,610,000 | +3.2% | 600,000 | 0.0% | 0.33% | -0.3% | |
| ACIU | AC IMMUNE SA | $8,520,000 | +72.1% | 1,000,000 | 0.0% | 0.33% | +66.2% | |
| BMRN | New | BIOMARIN PHARMACEUTICAL INCcall | $8,455,000 | – | 100,000 | +100.0% | 0.33% | – |
| SELB | Buy | SELECTA BIOSCIENCES INC | $8,124,000 | +121.1% | 3,413,629 | +62.6% | 0.31% | +113.6% |
| BPMC | New | BLUEPRINT MEDICINES CORPcall | $8,011,000 | – | 100,000 | +100.0% | 0.31% | – |
| SLDB | Buy | SOLID BIOSCIENCES INC | $8,010,000 | -54.4% | 1,800,000 | +5.9% | 0.31% | -56.2% |
| CLVS | New | CLOVIS ONCOLOGY INCcall | $7,819,000 | – | 750,000 | +100.0% | 0.30% | – |
| TGTX | Sell | TG THERAPEUTICS INC | $7,215,000 | +42.8% | 650,000 | -27.8% | 0.28% | +37.4% |
| NERV | MINERVA NEUROSCIENCES INC | $7,110,000 | -8.3% | 1,000,000 | 0.0% | 0.28% | -11.6% | |
| NIO | NIO INCcall | $7,035,000 | +157.7% | 1,750,000 | 0.0% | 0.27% | +149.5% | |
| MRUS | MERUS N V | $7,040,000 | -21.0% | 500,000 | 0.0% | 0.27% | -23.8% | |
| BBIO | BRIDGEBIO PHARMA INC | $7,010,000 | +63.3% | 200,000 | 0.0% | 0.27% | +57.6% | |
| DNLI | DENALI THERAPEUTICS INC | $6,968,000 | +13.7% | 400,000 | 0.0% | 0.27% | +9.3% | |
| AUTL | AUTOLUS THERAPEUTICS PLCsponsored ads | $6,600,000 | +6.3% | 500,000 | 0.0% | 0.26% | +2.4% | |
| IMUX | New | IMMUNIC INC | $6,111,000 | – | 630,019 | +100.0% | 0.24% | – |
| RGNX | REGENXBIO INC | $5,941,000 | +15.1% | 145,000 | 0.0% | 0.23% | +11.1% | |
| IGMS | Sell | IGM BIOSCIENCES INC | $5,724,000 | +61.2% | 150,000 | -25.0% | 0.22% | +55.6% |
| TCRR | Sell | TCR2 THERAPEUTICS INC | $5,712,000 | -19.5% | 400,000 | -15.2% | 0.22% | -22.2% |
| KURA | Buy | KURA ONCOLOGY INC | $5,500,000 | +45.0% | 400,000 | +60.0% | 0.21% | +39.5% |
| LGFA | LIONS GATE ENTMNT CORPcall | $5,330,000 | +15.2% | 500,000 | 0.0% | 0.21% | +11.4% | |
| TBIO | Sell | TRANSLATE BIO INC | $5,291,000 | -28.8% | 650,000 | -13.3% | 0.20% | -31.5% |
| FOLD | AMICUS THERAPEUTICS INCcall | $4,870,000 | +21.4% | 500,000 | 0.0% | 0.19% | +16.8% | |
| ORTX | ORCHARD THERAPEUTICS PLCads | $4,813,000 | +15.8% | 350,000 | 0.0% | 0.19% | +11.4% | |
| SPRO | Sell | SPERO THERAPEUTICS INC | $4,808,000 | -16.0% | 500,000 | -7.4% | 0.19% | -18.8% |
| PRTA | New | PROTHENA CORP PLC | $4,749,000 | – | 300,000 | +100.0% | 0.18% | – |
| ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $4,488,000 | -3.2% | 150,000 | 0.0% | 0.17% | -7.0% | |
| KRYS | Sell | KRYSTAL BIOTECH INC | $4,430,000 | -15.0% | 80,000 | -46.7% | 0.17% | -18.2% |
| YI | 111 INCads | $4,375,000 | +38.2% | 650,000 | 0.0% | 0.17% | +33.1% | |
| FATE | New | FATE THERAPEUTICS INCcall | $3,914,000 | – | 200,000 | +100.0% | 0.15% | – |
| ALEC | ALECTOR INC | $3,877,000 | +19.5% | 225,000 | 0.0% | 0.15% | +15.4% | |
| STML | STEMLINE THERAPEUTICS INC | $3,827,000 | +2.1% | 360,000 | 0.0% | 0.15% | -1.3% | |
| REAL | Sell | THE REALREAL INC | $3,770,000 | -70.2% | 200,000 | -64.6% | 0.15% | -71.2% |
| KRTX | New | KARUNA THERAPEUTICS INC | $3,767,000 | – | 50,000 | +100.0% | 0.15% | – |
| CYCN | CYCLERION THERAPEUTICS INC | $3,703,000 | -77.6% | 1,361,584 | 0.0% | 0.14% | -78.4% | |
| DOYU | DOUYU INTERNATIONAL HLDNGS Lsponsored ads | $3,388,000 | +3.4% | 400,000 | 0.0% | 0.13% | 0.0% | |
| SGMO | SANGAMO THERAPEUTICS INC | $3,390,000 | -7.5% | 405,000 | 0.0% | 0.13% | -10.9% | |
| NTLA | New | INTELLIA THERAPEUTICS INC | $2,930,000 | – | 199,700 | +100.0% | 0.11% | – |
| VKTX | VIKING THERAPEUTICS INC | $2,807,000 | +16.6% | 350,000 | 0.0% | 0.11% | +11.3% | |
| AKBA | AKEBIA THERAPEUTICS INC | $2,686,000 | +61.2% | 425,000 | 0.0% | 0.10% | +55.2% | |
| CRIS | New | CURIS INC | $2,550,000 | – | 1,500,000 | +100.0% | 0.10% | – |
| KLDO | Sell | KALEIDO BIOSCIENCES INC | $2,513,000 | -62.9% | 500,500 | -44.4% | 0.10% | -64.3% |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $2,292,000 | -0.7% | 300,000 | 0.0% | 0.09% | -3.3% | |
| TWST | TWIST BIOSCIENCE CORP | $2,100,000 | -12.1% | 100,000 | 0.0% | 0.08% | -15.6% | |
| AXLA | AXCELLA HEALTH INC | $1,805,000 | -29.1% | 450,000 | 0.0% | 0.07% | -31.4% | |
| IRWD | IRONWOOD PHARMACEUTICALS INC | $1,471,000 | +55.0% | 110,532 | 0.0% | 0.06% | +50.0% | |
| ADRO | ADURO BIOTECH INC | $1,180,000 | +11.3% | 1,000,000 | 0.0% | 0.05% | +9.5% | |
| AVRO | Exit | AVROBIO INC | $0 | – | -23,449 | -100.0% | -0.01% | – |
| SQ | Exit | SQUARE INCcl a | $0 | – | -30,000 | -100.0% | -0.08% | – |
| GRTS | Exit | GRITSTONE ONCOLOGY INC | $0 | – | -250,000 | -100.0% | -0.09% | – |
| ALLO | Exit | ALLOGENE THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.11% | – |
| NIO | Exit | NIO INCsponsored ads | $0 | – | -2,000,000 | -100.0% | -0.12% | – |
| TORC | Exit | RESTORBIO INC | $0 | – | -500,000 | -100.0% | -0.18% | – |
| ARQL | Exit | ARQULE INC | $0 | – | -850,000 | -100.0% | -0.24% | – |
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -500,000 | -100.0% | -0.36% | – |
| BOLD | Exit | AUDENTES THERAPEUTICS INC | $0 | – | -350,000 | -100.0% | -0.39% | – |
| FIS | Exit | FIDELITY NATL INFORMATION SV | $0 | – | -75,000 | -100.0% | -0.40% | – |
| DLPH | Exit | DELPHI TECHNOLOGIES PLCcall | $0 | – | -750,000 | -100.0% | -0.40% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -200,000 | -100.0% | -0.62% | – |
| BABA | Exit | ALIBABA GROUP HLDG LTDcall | $0 | – | -100,000 | -100.0% | -0.67% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -350,000 | -100.0% | -0.68% | – |
| XBI | Exit | SPDR SERIES TRUSTcall | $0 | – | -250,000 | -100.0% | -0.76% | – |
| NVDA | Exit | NVIDIA CORP | $0 | – | -200,000 | -100.0% | -1.40% | – |
| MDCO | Exit | MEDICINES CO | $0 | – | -1,400,000 | -100.0% | -2.81% | – |
| BAC | Exit | BANK AMER CORPcall | $0 | – | -3,000,000 | -100.0% | -3.51% | – |
| BMY | Exit | BRISTOL MYERS SQUIBB COcall | $0 | – | -3,500,000 | -100.0% | -7.12% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AGENUS INC | 42 | Q3 2023 | 1.9% |
| IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
| ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
| LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
| AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
| BEIGENE LTD | 28 | Q3 2023 | 7.4% |
| BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
| SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
| AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
| NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-25 |
| 4 | 2024-03-13 |
| 4 | 2024-02-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-16 |
| 13F-HR | 2023-08-11 |
| 4 | 2023-06-22 |
| 3 | 2023-06-15 |
| 4 | 2023-06-05 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.